Edition:
United States

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

1.57USD
20 Aug 2018
Change (% chg)

-- (--)
Prev Close
$1.57
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
110,688
52-wk High
$11.41
52-wk Low
$0.83

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.469
Mar '18 0.00 -0.581
FY 2017 Dec '17 0.00 -0.634
Sep '17 0.00 -0.816
Jun '17 0.00 -0.990
Mar '17 0.00 -0.787
FY 2016 Dec '16 0.00 -0.306
Sep '16 0.00 -0.565
Jun '16 0.00 -0.166
Mar '16 0.00 -0.267
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 0.00 0.00 0.00 --
Quarter Ending Dec-18 5 0.00 0.00 0.00 --
Year Ending Dec-18 5 0.00 0.00 0.00 2.19
Year Ending Dec-19 4 1.10 4.40 0.00 8.80
Earnings (per share)
Quarter Ending Sep-18 5 -0.50 -0.41 -0.60 --
Quarter Ending Dec-18 5 -0.47 -0.37 -0.60 --
Year Ending Dec-18 5 -2.05 -1.86 -2.28 -2.15
Year Ending Dec-19 5 -2.38 -1.59 -3.37 -2.26
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 99.36 30.45
P/E High - Last 5 Yrs. -- 272.05 47.36
P/E Low - Last 5 Yrs. -- 95.21 24.74
Beta -- 0.78 0.84
Price to Sales (TTM) -- 126.22 5.98
Price to Book (MRQ) 1.48 13.00 3.69
Price to Tangible Book (MRQ) 1.56 22.28 5.63
Price to Cash Flow (TTM) -- 64.21 20.97
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.37 1.78
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.47 -5.93
Payout Ratio(TTM) -- 6.14 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 158.89 7.18
Sales (TTM) vs TTM 1 Yr. Ago -- 91.20 12.05
Sales - 5 Yr. Growth Rate -- 24.34 7.61
EPS (MRQ) vs Qtr. 1 Yr. Ago 52.63 74.27 23.85
EPS (TTM) vs TTM 1 Yr. Ago 5.59 -- --
EPS - 5 Yr. Growth Rate -- 23.23 7.52
Capital Spending - 5 Yr. Growth Rate -- 36.95 8.06

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.73 2.50
Current Ratio (MRQ) 4.63 5.42 3.53
LT Debt to Equity (MRQ) 50.11 19.75 11.27
Total Debt to Equity (MRQ) 67.73 23.48 14.23
Interest Coverage (TTM) -65.56 -186.89 31.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 57.13 55.23
Gross Margin - 5 Yr. Avg. -- 52.64 53.33
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -189.34 15.82
Operating Margin (TTM) -- -673.76 3.86
Operating Margin - 5 Yr. Avg. -- -202.74 10.95
Pre-Tax Margin (TTM) -- -665.74 4.16
Pre-Tax Margin - 5 Yr. Avg. -- -203.67 11.12
Net Profit Margin (TTM) -- -655.99 0.98
Net Profit Margin - 5 Yr. Avg. -- -201.27 7.47
Effective Tax Rate (TTM) -- 12.18 20.36
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 5,071,848 718,909,906
Net Income/Employee (TTM) -1,628,833 -6,208,777 83,624,743
Receivable Turnover (TTM) -- 6.39 5.38
Inventory Turnover (TTM) -- 2.25 3.51
Asset Turnover (TTM) 0.00 0.42 0.83

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -113.18 1.88 10.04
Return on Assets - 5 Yr. Avg. -- 2.31 10.94
Return on Investment (TTM) -145.42 2.89 12.63
Return on Investment - 5 Yr. Avg. -- 1.68 14.14
Return on Equity (TTM) -178.89 1.65 14.82
Return on Equity - 5 Yr. Avg. -- -6.94 15.50
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -25.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Gemphire Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 31.60%
# of Holders: 44
Total Shares Held: 4,507,446
3 Mo. Net Change: -213,085
# New Positions: 16
# Closed Positions: 6
# Increased Positions: 26
# Reduced Positions: 12
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.